NCT05334706 2026-02-23
RIFT-HPV
Institut d'Investigació Biomèdica de Bellvitge
Phase 4 Recruiting
Clinical Trials
12 trialsNCT04206813 2026-01-27
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
Boston Medical Center
Phase 4 Active not recruiting
NCT04474821 2026-01-12
HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults
Mayo Clinic
Phase 4 Completed
NCT06538480 2025-12-15
Zopa Retreatment and Vector Shedding in Adults With RRP
Precigen, Inc
Phase 4 Recruiting
NCT07281677 2025-12-15
Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years
Zhejiang Provincial Center for Disease Control and Prevention
Phase 4 Recruiting
NCT05672927 2025-10-06
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
The University of Texas Medical Branch, Galveston
Phase 4 Recruiting
NCT04953130 2025-09-10
Add-Vacc
London School of Hygiene and Tropical Medicine
Phase 4 Active not recruiting
NCT03180034 2025-09-04
ESCUDDO
National Cancer Institute (NCI)
Phase 4 Active not recruiting
NCT04982614 2025-08-24
HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini
Columbia University
Phase 4 Completed
NCT05266898 2025-04-18
AGO-Gard
Louisiana State University Health Sciences Center in New Orleans
Phase 4 Recruiting
NCT04235257 2025-03-27
Intradermal, Fractional Dose of HPV Vaccines:
University of Washington
Phase 4 Active not recruiting
NCT05291871 2025-03-27
Immunogenicity of Fractional Dose of the HPV Vaccines
University of Washington
Phase 4 Active not recruiting